Vaccine · BLA
M-M-R II NDC 0006-4681
measles, mumps, and rubella virus vaccine live · Measles virus strain enders' attenuated edmonston live antigen 1000 [TCID_50]/.5mL + 2 more ingredients · Injection, Powder, Lyophilized, For suspension · Intramuscular, Subcutaneous · Merck Sharp & Dohme LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0006-4681-00 | 00006468100 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4681-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4681-01)Marketed from Apr 21, 1971 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- M-M-R II
- Generic name (nonproprietary)
- measles, mumps, and rubella virus vaccine live
- Active ingredients
- Measles virus strain enders' attenuated edmonston live antigen — 1000 [TCID_50]/.5mLMumps virus strain b level jeryl lynn live antigen — 12500 [TCID_50]/.5mLRubella virus strain wistar ra 27/3 live antigen — 1000 [TCID_50]/.5mL
- Dosage form
- Injection, Powder, Lyophilized, For suspension
- Route
- Intramuscular, Subcutaneous
- Labeler
- Merck Sharp & Dohme LLC
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 101069
- Marketing start
- Listing expires
- Other FDA classes
- Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Measles Vaccine (Chemical structure)Mumps Vaccine (Chemical structure)Rubella Vaccine (Chemical structure)Attenuated (Chemical structure)Attenuated (Chemical structure)Attenuated (Chemical structure)
- Identifiers
- Product ID 0006-4681_4304efd3-eca8-4b1a-bc87-3426d9f5bf73SPL ID 4304efd3-eca8-4b1a-bc87-3426d9f5bf73
- Pharmacologic class
- Live Attenuated Measles Virus Vaccine; Live Attenuated Mumps Virus Vaccine; Live Attenuated Rubella Virus Vaccine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N400006468100followed by a unit qualifier and the quantityPackage 00006-4681-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
Other NDCs under BLA 101069
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sterile Diluentsterile water | Water .7 mL/.7mL | InjectionIntramuscular, Subcutaneous | Merck Sharp & Dohme LLC | 0006-4175 |